Incyte Gross Margin 2012-2025 | INCY

Current and historical gross margin for Incyte (INCY) over the last 10 years. The current gross profit margin for Incyte as of September 30, 2025 is %.

Incyte Gross Margin Historical Data
Date	TTM Revenue	TTM Gross Profit	Gross Margin
2025-09-30	$4.81B	$4.47B	92.94%
2025-06-30	$4.59B	$4.26B	92.87%
2025-03-31	$4.41B	$4.09B	92.64%
2024-12-31	$4.24B	$3.93B	92.62%
2024-09-30	$4.08B	$3.78B	92.81%
2024-06-30	$3.86B	$3.59B	93.08%
2024-03-31	$3.77B	$3.51B	93.13%
2023-12-31	$3.70B	$3.44B	93.10%
2023-09-30	$3.61B	$3.37B	93.21%
2023-06-30	$3.51B	$3.28B	93.20%
2023-03-31	$3.47B	$3.25B	93.66%
2022-12-31	$3.39B	$3.19B	93.96%
2022-09-30	$3.33B	$3.14B	94.29%
2022-06-30	$3.32B	$3.14B	94.70%
2022-03-31	$3.12B	$2.95B	94.74%
2021-12-31	$2.99B	$2.84B	94.91%
2021-09-30	$2.91B	$2.77B	95.02%
2021-06-30	$2.72B	$2.58B	94.86%
2021-03-31	$2.70B	$2.57B	95.01%
2020-12-31	$2.67B	$2.54B	95.01%
2020-09-30	$2.46B	$2.33B	94.79%
2020-06-30	$2.39B	$2.27B	94.85%
2020-03-31	$2.23B	$2.11B	94.66%
2019-12-31	$2.16B	$2.05B	94.72%
2019-09-30	$2.11B	$2.00B	94.88%
2019-06-30	$2.01B	$1.90B	94.87%
2019-03-31	$2.00B	$1.90B	95.05%
2018-12-31	$1.88B	$1.79B	95.01%
2018-09-30	$1.80B	$1.71B	94.99%
2018-06-30	$1.73B	$1.64B	94.91%
2018-03-31	$1.53B	$1.45B	94.59%
2017-12-31	$1.54B	$1.46B	94.79%
2017-09-30	$1.42B	$1.34B	94.57%
2017-06-30	$1.31B	$1.23B	94.33%
2017-03-31	$1.23B	$1.16B	94.61%
2016-12-31	$1.10B	$1.05B	94.84%
2016-09-30	$1.02B	$0.97B	95.30%
2016-06-30	$0.94B	$0.91B	96.17%
2016-03-31	$0.86B	$0.83B	96.50%
2015-12-31	$0.75B	$0.73B	96.42%
2015-09-30	$0.63B	$0.62B	97.00%
2015-06-30	$0.64B	$0.63B	98.29%
2015-03-31	$0.58B	$0.58B	98.97%
2014-12-31	$0.51B	$0.51B	99.41%
2014-09-30	$0.49B	$0.48B	99.79%
2014-06-30	$0.37B	$0.37B	99.73%
2014-03-31	$0.37B	$0.37B	100.00%
2013-12-31	$0.36B	$0.36B	100.00%
2013-09-30	$0.37B	$0.37B	100.00%
2013-06-30	$0.35B	$0.35B	100.00%
2013-03-31	$0.33B	$0.33B	100.00%
2012-12-31	$0.30B	$0.30B	100.00%
2012-09-30	$0.21B	$0.21B	100.00%
2012-06-30	$0.17B	$0.17B	100.00%
2012-03-31	$0.10B	$0.10B	100.00%
2011-12-31	$0.10B	$0.10B	100.00%
2011-09-30	$0.15B	$0.15B	100.00%
2011-06-30	$0.15B	$0.15B	100.00%
2011-03-31	$0.19B	$0.19B	100.00%
2010-12-31	$0.17B	$0.17B	100.00%
2010-09-30	$0.09B	$0.09B	100.00%
2010-06-30	$0.08B	$0.08B	100.00%
2010-03-31	$0.03B	$0.03B	100.00%
2009-12-31	$0.01B	$0.01B	100.00%
2009-09-30	$0.00B	$0.00B	100.00%
2009-06-30	$0.00B	$0.00B	100.00%
2009-03-31	$0.00B	$0.00B	100.00%
2008-12-31	$0.00B	$0.00B	100.00%
2008-09-30	$0.01B	$0.01B	100.00%
2008-06-30	$0.02B	$0.02B	100.00%
2008-03-31	$0.03B	$0.03B	100.00%
2007-12-31	$0.04B	$0.04B	100.00%
2007-09-30	$0.03B	$0.03B	100.00%
2007-06-30	$0.03B	$0.03B	100.00%
2007-03-31	$0.03B	$0.03B	100.00%
2006-12-31	$0.03B	$0.03B	100.00%
2006-09-30	$0.02B	$0.02B	100.00%
2006-06-30	$0.02B	$0.02B	100.00%
2006-03-31	$0.01B	$0.01B	100.00%
2005-12-31	$0.01B	$0.01B	100.00%
2005-09-30	$0.01B	$0.01B	100.00%
2005-06-30	$0.01B	$0.01B	100.00%
2005-03-31	$0.01B	$0.01B	100.00%
2004-12-31	$0.01B	$0.01B	100.00%
2004-09-30	$0.02B	$0.02B	100.00%
2004-06-30	$0.03B	$0.03B	100.00%
2004-03-31	$0.03B	$0.03B	100.00%
2003-12-31	$0.04B	$0.04B	100.00%
2003-09-30	$0.05B	$0.05B	100.00%
2003-06-30	$0.06B	$0.06B	100.00%
2003-03-31	$0.08B	$0.08B	100.00%
2002-12-31	$0.10B	$0.10B	100.00%
2002-09-30	$0.14B	$0.14B	100.00%
2002-06-30	$0.17B	$0.17B	100.00%
2002-03-31	$0.20B	$0.20B	100.00%
2001-12-31	$0.22B	$0.22B	100.00%
2001-09-30	$0.22B	$0.22B	100.00%
2001-06-30	$0.21B	$0.21B	100.00%
2001-03-31	$0.20B	$0.20B	100.00%
2000-12-31	$0.19B	$0.19B	100.00%
2000-09-30	$0.19B	$0.19B	100.00%
2000-06-30	$0.17B	$0.17B	100.00%
2000-03-31	$0.16B	$0.16B	100.00%
1999-12-31	$0.16B	$0.16B	100.00%
1999-09-30	$0.15B	$0.15B	100.00%
1999-06-30	$0.15B	$0.15B	100.00%
1999-03-31	$0.14B	$0.14B	100.00%
1998-12-31	$0.14B	$0.14B	100.00%
1998-09-30	$0.13B	$0.13B	100.00%
1998-06-30	$0.11B	$0.11B	100.00%
1998-03-31	$0.10B	$0.10B	100.00%
1997-12-31	$0.09B	$0.09B	100.00%
1997-09-30	$0.08B	$0.08B	100.00%
1997-06-30	$0.07B	$0.07B	100.00%
1997-03-31	$0.05B	$0.05B	100.00%
1996-12-31	$0.04B	$0.04B	100.00%
1996-09-30	$0.03B	$0.03B	100.00%
1996-06-30	$0.02B	$0.02B	100.00%
1996-03-31	$0.02B	$0.02B	100.00%
1995-12-31	$0.01B	$0.01B	100.00%
1995-09-30	$0.01B	$0.01B	100.00%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$20.051B	$5.141B
Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. The company conducts its European clinical development operations in Geneva, Switzerland. Incyte's lead drug, Jakafi (ruxolitinib), is a first-in-class JAK1/JAK2 inhibitor, approved in the United States for the treatment of patients with polycythemia vera ('PV'),who have had an inadequate response to or are intolerant to hydroxyurea. It is also approved for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-PV MF, and post-essential thrombocythemia MF. The drug is also approved in the United States for treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients aged 12 years or older.

Stock Name	Country	Market Cap	PE Ratio
AstraZeneca (AZN)	United Kingdom	$317.192B	25.25
Amgen (AMGN)	United States	$197.192B	16.76
Gilead Sciences (GILD)	United States	$188.348B	18.63
Bristol Myers Squibb (BMY)	United States	$121.903B	9.73
GSK (GSK)	United Kingdom	$119.328B	12.95
Vertex Pharmaceuticals (VRTX)	United States	$117.984B	28.32
Regeneron Pharmaceuticals (REGN)	United States	$82.361B	21.72
CSL (CSLLY)	Australia	$52.484B	0.00
Argenex SE (ARGX)	Netherlands	$51.582B	63.73
Alnylam Pharmaceuticals (ALNY)	United States	$40.754B	181.46
Insmed (INSM)	United States	$31.174B	0.00
Biogen (BIIB)	United States	$28.691B	12.79
Royalty Pharma (RPRX)	United States	$25.860B	9.28
BioNTech SE (BNTX)	Germany	$23.815B	0.00
Exact Sciences (EXAS)	United States	$19.697B	543.32
Genmab (GMAB)	Denmark	$19.008B	14.30
Revolution Medicines (RVMD)	United States	$18.816B	0.00
Roivant Sciences (ROIV)	United Kingdom	$18.604B	0.00
Illumina (ILMN)	United States	$17.486B	23.60
Sino Biopharmaceutical (SBMFF)	Hong Kong, SAR China	$15.757B	0.00
Moderna (MRNA)	United States	$15.672B	0.00
Regencell Bioscience Holdings (RGC)	Hong Kong, SAR China	$14.350B	0.00
Ascendis Pharma (ASND)	Denmark	$13.517B	0.00
Swedish Orphan Biovitrum (BIOVF)	Sweden	$13.172B	21.26
Guardant Health (GH)	United States	$12.952B	0.00
BioMarin Pharmaceutical (BMRN)	United States	$11.515B	20.89
Avidity Biosciences (RNA)	United States	$11.282B	0.00
Exelixis (EXEL)	United States	$11.090B	15.64
QIAGEN (QGEN)	Netherlands	$10.738B	20.57
Jazz Pharmaceuticals (JAZZ)	Ireland	$10.105B	39.40
Abivax SA (ABVX)	France	$9.769B	0.00
Bio-Techne Corp (TECH)	United States	$9.315B	33.83
Axsome Therapeutics (AXSM)	United States	$9.222B	0.00
Halozyme Therapeutics (HALO)	United States	$9.046B	14.46
Arrowhead Pharmaceuticals (ARWR)	United States	$8.735B	40.77
Praxis Precision Medicines (PRAX)	United States	$8.388B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$7.959B	29.74
Cytokinetics (CYTK)	United States	$7.952B	0.00
Krystal Biotech (KRYS)	United States	$7.837B	40.52
Repligen (RGEN)	United States	$7.466B	79.90
Nuvalent (NUVL)	United States	$7.367B	0.00
Vaxcyte (PCVX)	United States	$7.193B	0.00
Cidara Therapeutics (CDTX)	United States	$6.960B	0.00
Merus (MRUS)	Netherlands	$6.826B	0.00
Belite Bio (BLTE)	United States	$6.550B	0.00
ImmunityBio (IBRX)	United States	$6.520B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$6.411B	0.00
Kymera Therapeutics (KYMR)	United States	$6.045B	0.00
PTC Therapeutics (PTCT)	United States	$5.676B	7.71
Alkermes (ALKS)	Ireland	$5.497B	16.16
Mirum Pharmaceuticals (MIRM)	United States	$5.243B	0.00
Cogent Biosciences (COGT)	United States	$5.228B	0.00
Immunovant (IMVT)	United States	$5.219B	0.00
Protagonist Therapeutics (PTGX)	United States	$5.122B	132.15
Celcuity (CELC)	United States	$4.852B	0.00
Scholar Rock Holding (SRRK)	United States	$4.760B	0.00
Apogee Therapeutics (APGE)	United States	$4.735B	0.00
CRISPR Therapeutics AG (CRSP)	Switzerland	$4.663B	0.00
Zealand Pharma (ZLDPF)	Denmark	$4.534B	4.59
TG Therapeutics (TGTX)	United States	$4.512B	10.22
Akero Therapeutics (AKRO)	United States	$4.499B	0.00
Amicus Therapeutics (FOLD)	United States	$4.498B	358.25
Structure Therapeutics (GPCR)	United States	$4.371B	0.00
CG Oncology (CGON)	United States	$4.164B	0.00
Arcellx (ACLX)	United States	$3.970B	0.00
Terns Pharmaceuticals (TERN)	United States	$3.917B	0.00
Erasca (ERAS)	United States	$3.811B	0.00
GRAIL (GRAL)	United States	$3.738B	0.00
ADMA Biologics Inc (ADMA)	United States	$3.710B	26.42
ACADIA Pharmaceuticals (ACAD)	United States	$3.656B	30.87
Anbio Biotechnology (NNNN)	Germany	$3.630B	0.00
Ligand Pharmaceuticals (LGND)	United States	$3.575B	87.75
Viking Therapeutics (VKTX)	United States	$3.523B	0.00
Liquidia (LQDA)	United States	$3.396B	0.00
Kiniksa Pharmaceuticals (KNSA)	United Kingdom	$3.389B	99.36
Legend Biotech (LEGN)	United States	$3.335B	0.00
Arcutis Biotherapeutics (ARQT)	United States	$3.272B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$3.216B	0.00
Edgewise Therapeutics (EWTX)	United States	$3.215B	0.00
Vera Therapeutics (VERA)	United States	$2.958B	0.00
Twist Bioscience (TWST)	United States	$2.922B	0.00
Denali Therapeutics (DNLI)	United States	$2.813B	0.00
Alumis (ALMS)	United States	$2.798B	0.00
Apellis Pharmaceuticals (APLS)	United States	$2.790B	71.13
IDEAYA Biosciences (IDYA)	United States	$2.763B	0.00
Viridian Therapeutics (VRDN)	United States	$2.744B	0.00
Travere Therapeutics (TVTX)	United States	$2.738B	0.00
Beam Therapeutics (BEAM)	United States	$2.733B	0.00
Disc Medicine (IRON)	United States	$2.705B	0.00
Spyre Therapeutics (SYRE)	United States	$2.703B	0.00
Tarsus Pharmaceuticals (TARS)	United States	$2.685B	0.00
HUTCHMED (China) (HCM)	Hong Kong, SAR China	$2.573B	0.00
Immunome (IMNM)	United States	$2.476B	0.00
Bavarian Nordic (BVNRY)	Denmark	$2.412B	6.55
Adaptive Biotechnologies (ADPT)	United States	$2.372B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$2.267B	0.00
Maze Therapeutics (MAZE)	United States	$2.264B	0.00
Mineralys Therapeutics (MLYS)	United States	$2.205B	0.00
Mesoblast (MESO)	Australia	$2.179B	0.00
Telix Pharmaceuticals (TLX)	Australia	$2.178B	0.00
Ascentage Pharma Group - (AAPG)	China	$2.165B	0.00
Arcus Biosciences (RCUS)	United States	$2.155B	0.00
WAVE Life Sciences (WVE)	Singapore	$2.140B	0.00
Zai Lab (ZLAB)	China	$2.102B	0.00
Harmony Biosciences Holdings (HRMY)	United States	$2.065B	11.27
Dianthus Therapeutics (DNTH)	United States	$2.052B	0.00
Nuvation Bio (NUVB)	United States	$1.985B	0.00
Recursion Pharmaceuticals (RXRX)	United States	$1.861B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$1.837B	0.00
Sarepta Therapeutics (SRPT)	United States	$1.823B	0.00
Stoke Therapeutics (STOK)	United States	$1.821B	47.60
Dynavax Technologies (DVAX)	United States	$1.819B	53.41
Zymeworks (ZYME)	United States	$1.734B	0.00
MannKind (MNKD)	United States	$1.729B	56.30
ANI Pharmaceuticals (ANIP)	United States	$1.723B	13.36
Vericel (VCEL)	United States	$1.718B	141.54
Tango Therapeutics (TNGX)	United States	$1.706B	0.00
MBX Biosciences (MBX)	United States	$1.706B	0.00
Sionna Therapeutics (SION)	United States	$1.680B	0.00
Precigen (PGEN)	United States	$1.677B	0.00
Agios Pharmaceuticals (AGIO)	United States	$1.637B	0.00
Olema Pharmaceuticals (OLMA)	United States	$1.631B	0.00
Nurix Therapeutics (NRIX)	United States	$1.618B	0.00
Immunocore Holdings (IMCR)	United Kingdom	$1.606B	0.00
Rapt Therapeutics (RAPT)	United States	$1.602B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$1.571B	0.00
Celldex Therapeutics (CLDX)	United States	$1.566B	0.00
Tyra Biosciences (TYRA)	United States	$1.558B	0.00
AnaptysBio (ANAB)	United States	$1.520B	0.00
Oculis Holding AG (OCS)	Switzerland	$1.495B	0.00
Mind Medicine (MindMed) (MNMD)	United States	$1.480B	0.00
NeoGenomics (NEO)	United States	$1.445B	0.00
Alvotech (ALVO)	Luxembourg	$1.420B	20.48
NovoCure (NVCR)	Jersey	$1.403B	0.00
Trevi Therapeutics (TRVI)	United States	$1.403B	0.00
Zenas BioPharma (ZBIO)	United States	$1.402B	0.00
UniQure (QURE)	Netherlands	$1.393B	0.00
Novavax (NVAX)	United States	$1.368B	3.48
Intellia Therapeutics (NTLA)	United States	$1.346B	0.00
Rapport Therapeutics (RAPP)	United States	$1.333B	0.00
AtaiBeckley Inc (ATAI)	Netherlands	$1.300B	0.00
Biohaven (BHVN)	United States	$1.217B	0.00
Monte Rosa Therapeutics (GLUE)	United States	$1.205B	57.81
Immatics (IMTX)	Germany	$1.203B	0.00
Oxford BioMedica (OXBDF)	United Kingdom	$1.202B	0.00
Inhibrx Biosciences (INBX)	United States	$1.194B	0.00
Nanobiotix S.A - (NBTX)	France	$1.185B	0.00
Kodiak Sciences (KOD)	United States	$1.167B	0.00
Septerna (SEPN)	United States	$1.153B	0.00
Day One Biopharmaceuticals (DAWN)	United States	$1.129B	0.00
Compass Therapeutics (CMPX)	United States	$1.128B	0.00
EyePoint (EYPT)	United States	$1.077B	0.00
Pharming Group (PHAR)	Netherlands	$1.073B	0.00
Vir Biotechnology (VIR)	United States	$1.073B	0.00
Certara (CERT)	United States	$1.062B	19.62
Geron (GERN)	United States	$1.041B	0.00
Sana Biotechnology (SANA)	United States	$1.010B	0.00
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.003B	0.00
Iovance Biotherapeutics (IOVA)	United States	$1.000B	0.00
Ventyx Biosciences (VTYX)	United States	$1.000B	0.00
Oric Pharmaceuticals (ORIC)	United States	$0.997B	0.00
Palvella Therapeutics (PVLA)	United States	$0.971B	0.00
Fortrea Holdings (FTRE)	United States	$0.949B	20.14
Urogen Pharma (URGN)	United States	$0.946B	0.00
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$0.935B	0.00
Castle Biosciences (CSTL)	United States	$0.931B	127.60
CureVac (CVAC)	Germany	$0.927B	0.00
ArriVent BioPharma (AVBP)	United States	$0.926B	0.00
Pacira BioSciences (PCRX)	United States	$0.923B	10.57
CytomX Therapeutics (CTMX)	United States	$0.920B	13.57
BridgeBio Oncology Therapeutics (BBOT)	United States	$0.913B	0.00
Inventiva S.A (IVA)	France	$0.905B	0.00
AbCellera Biologics (ABCL)	Canada	$0.880B	0.00
Evommune (EVMN)	United States	$0.879B	0.00
DBV Technologies S.A (DBVT)	France	$0.871B	0.00
Phathom Pharmaceuticals (PHAT)	United States	$0.858B	0.00
Janux Therapeutics (JANX)	United States	$0.790B	0.00
Bright Minds Biosciences (DRUG)	United States	$0.784B	0.00
MapLight Therapeutics (MPLT)	United States	$0.781B	0.00
GH Research (GHRS)	Ireland	$0.781B	0.00
Arbutus Biopharma (ABUS)	United States	$0.771B	0.00
Bicara Therapeutics (BCAX)	United States	$0.770B	0.00
Arvinas (ARVN)	United States	$0.760B	0.00
MiMedx (MDXG)	United States	$0.754B	13.40
Gyre Therapeutics (GYRE)	United States	$0.753B	97.75
Jade Biosciences (JBIO)	United States	$0.730B	0.00
Astria Therapeutics (ATXS)	United States	$0.718B	0.00
BioAge Labs (BIOA)	United States	$0.715B	0.00
Kura Oncology (KURA)	United States	$0.698B	0.00
YD Bio (YDES)		$0.692B	0.00
Upstream Bio (UPB)	United States	$0.692B	0.00
Cullinan Therapeutics (CGEM)	United States	$0.691B	0.00
EnGene Holdings (ENGN)	Canada	$0.666B	0.00
Replimune (REPL)	United States	$0.659B	0.00
Sinovac Biotech (SVA)	China	$0.645B	0.00
Annexon (ANNX)	United States	$0.621B	0.00
LB Pharmaceuticals Inc (LBRX)	United States	$0.616B	0.00
Prime Medicine (PRME)	United States	$0.599B	0.00
MeiraGTx Holdings (MGTX)	United States	$0.592B	0.00
Fulcrum Therapeutics (FULC)	United States	$0.588B	0.00
CorMedix Inc (CRMD)	United States	$0.580B	5.37
Design Therapeutics (DSGN)	United States	$0.572B	0.00
Emergent Biosolutions (EBS)	United States	$0.570B	5.48
Neumora Therapeutics (NMRA)	United States	$0.543B	0.00
Gossamer Bio (GOSS)	United States	$0.537B	0.00
Cytek Biosciences (CTKB)	United States	$0.533B	0.00
Ginkgo Bioworks Holdings (DNA)	United States	$0.533B	0.00
Alto Neuroscience (ANRO)	United States	$0.511B	0.00
Keros Therapeutics (KROS)	United States	$0.506B	10.79
SELLAS Life Sciences (SLS)	United States	$0.506B	0.00
ADC Therapeutics SA (ADCT)	Switzerland	$0.498B	0.00
Kamada (KMDA)	Israel	$0.493B	23.81
Prothena (PRTA)	Ireland	$0.476B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.476B	0.00
Solid Biosciences (SLDB)	United States	$0.474B	0.00
PepGen (PEPG)	United States	$0.467B	0.00
Eton Pharmaceuticals (ETON)	United States	$0.450B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.449B	0.00
Ocugen (OCGN)	United States	$0.440B	0.00
Contineum Therapeutics (CTNM)	United States	$0.434B	0.00
Tectonic Therapeutic (TECX)	United States	$0.425B	0.00
REGENXBIO (RGNX)	United States	$0.423B	0.00
Myriad Genetics (MYGN)	United States	$0.422B	0.00
PureTech Health (PRTC)	United States	$0.422B	0.00
GENFIT S.A (GNFTY)	France	$0.417B	0.00
Entrada Therapeutics (TRDA)	United States	$0.413B	0.00
Niagen Bioscience (NAGE)	United States	$0.406B	31.81
LENZ Therapeutics (LENZ)	United States	$0.406B	0.00
Prima BioMed (IMMP)	Australia	$0.404B	0.00
Zura Bio (ZURA)	United States	$0.404B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$0.402B	0.00
Monopar Therapeutics (MNPR)	United States	$0.396B	0.00
Immix Biopharma (IMMX)	United States	$0.393B	0.00
Verastem (VSTM)	United States	$0.390B	0.00
Benitec Biopharma (BNTC)	United States	$0.388B	0.00
Forte Biosciences (FBRX)	United States	$0.386B	0.00
Northwest Biotherapeutics (NWBO)	United States	$0.383B	0.00
NovaBridge Biosciences (NBP)	United States	$0.374B	0.00
Bicycle Therapeutics (BCYC)	United Kingdom	$0.372B	0.00
Autolus Therapeutics (AUTL)	United Kingdom	$0.367B	0.00
Allogene Therapeutics (ALLO)	United States	$0.364B	0.00
Absci (ABSI)	United States	$0.364B	0.00
Anavex Life Sciences (AVXL)	United States	$0.363B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.362B	0.00
Climb Bio (CLYM)	United States	$0.359B	0.00
Invivyd (IVVD)	United States	$0.357B	0.00
Greenwich LifeSciences (GLSI)	United States	$0.356B	0.00
Adlai Nortye (ANL)	Cayman Islands	$0.356B	0.00
Prenetics Global (PRE)	Hong Kong, SAR China	$0.353B	0.00
Rocket Pharmaceuticals (RCKT)	United States	$0.352B	0.00
Aura Biosciences (AURA)	United States	$0.350B	0.00
Puma Biotechnology (PBYI)	United States	$0.343B	9.19
Atea Pharmaceuticals (AVIR)	United States	$0.338B	0.00
Rezolute (RZLT)	United States	$0.337B	0.00
Kyverna Therapeutics (KYTX)	United States	$0.322B	0.00
Immuneering (IMRX)	United States	$0.320B	0.00
Amarin (AMRN)	Ireland	$0.309B	0.00
Candel Therapeutics (CADL)	United States	$0.307B	0.00
Foghorn Therapeutics (FHTX)	United States	$0.297B	0.00
X4 Pharmaceuticals (XFOR)	United States	$0.295B	0.00
AC Immune (ACIU)	Switzerland	$0.294B	0.00
Eupraxia Pharmaceuticals (EPRX)	Canada	$0.292B	0.00
XOMA Royalty (XOMA)	United States	$0.292B	0.00
Adherex Technologies (FENC)	United States	$0.281B	0.00
Cabaletta Bio (CABA)	United States	$0.274B	0.00
Abeona Therapeutics (ABEO)	United States	$0.270B	4.42
Nautilus Biotechnology (NAUT)	United States	$0.269B	0.00
Aardvark Therapeutics (AARD)	United States	$0.267B	0.00
Neurogene (NGNE)	United States	$0.263B	0.00
Lifecore Biomedical (LFCR)	United States	$0.262B	0.00
Palisade Bio (PALI)	United States	$0.259B	0.00
Shattuck Labs (STTK)	United States	$0.247B	0.00
Coherus Oncology (CHRS)	United States	$0.243B	0.00
Opus Genetics (IRD)	United States	$0.234B	0.00
Nuvectis Pharma (NVCT)	United States	$0.233B	0.00
Adocia (ADOCY)	France	$0.231B	0.00
Orchestra BioMed Holdings (OBIO)	United States	$0.216B	0.00
Alector (ALEC)	United States	$0.207B	0.00
CAMP4 Therapeutics (CAMP)	United States	$0.206B	0.00
Arcturus Therapeutics Holdings (ARCT)	United States	$0.204B	0.00
SAB Biotherapeutics (SABS)	United States	$0.196B	0.00
Voyager Therapeutics (VYGR)	United States	$0.190B	0.00
Humacyte (HUMA)	United States	$0.189B	0.00
Molecular Partners AG (MOLN)	Switzerland	$0.188B	0.00
C4 Therapeutics (CCCC)	United States	$0.177B	0.00
Satellos Bioscience (MSLE)	Canada	$0.174B	0.00
Tiziana Life Sciences (TLSA)	United Kingdom	$0.169B	0.00
Zentalis Pharmaceuticals (ZNTL)	United States	$0.169B	0.00
Kalaris Therapeutics (KLRS)	United States	$0.168B	0.00
Sagimet Biosciences (SGMT)	United States	$0.167B	0.00
Cartesian Therapeutics (RNAC)	United States	$0.167B	0.00
Editas Medicine (EDIT)	United States	$0.164B	0.00
Tharimmune (THAR)	United States	$0.161B	0.00
Innate Pharma S.A (IPHA)	France	$0.156B	0.00
Rani Therapeutics Holdings (RANI)	United States	$0.152B	0.00
Alps Group (ALPS)	United States	$0.150B	2.73
Starpharma Holdings (SPHRY)	Australia	$0.149B	0.00
Elicio Therapeutics (ELTX)	United States	$0.147B	0.00
Milestone Pharmaceuticals (MIST)	Canada	$0.146B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.146B	0.00
Mersana Therapeutics (MRSN)	United States	$0.145B	0.00
Anika Therapeutics (ANIK)	United States	$0.145B	0.00
Acumen Pharmaceuticals (ABOS)	United States	$0.145B	0.00
VTv Therapeutics (VTVT)	United States	$0.144B	0.00
Caribou Biosciences (CRBU)	United States	$0.142B	0.00
Whitehawk Therapeutics (WHWK)	United States	$0.142B	0.00
Nkarta (NKTX)	United States	$0.140B	0.00
Fate Therapeutics (FATE)	United States	$0.138B	0.00
Connect Biopharma Holdings (CNTB)	United States	$0.138B	0.00
Vor Biopharma (VOR)		$0.136B	0.00
Adagene (ADAG)	China	$0.134B	0.00
Spero Therapeutics (SPRO)	United States	$0.134B	0.00
Sutro Biopharma (STRO)	United States	$0.133B	0.00
ALX Oncology Holdings (ALXO)	United States	$0.130B	0.00
Crescent Biopharma (CBIO)	United States	$0.128B	0.00
Sangamo Therapeutics (SGMO)	United States	$0.127B	0.00
Black Diamond Therapeutics (BDTX)	United States	$0.125B	6.08
Eledon Pharmaceuticals (ELDN)	United States	$0.120B	0.00
Alpha Cognition (ACOG)	Canada	$0.115B	0.00
Repare Therapeutics (RPTX)	Canada	$0.114B	0.00
Alpha Teknova (TKNO)	United States	$0.114B	0.00
Tenaya Therapeutics (TNYA)	United States	$0.112B	0.00
Jyong Biotech (MENS)	Taiwan	$0.112B	0.00
BGM Group (BGM)	China	$0.110B	0.00
Fortress Biotech (FBIO)	United States	$0.108B	0.00
Seer (SEER)	United States	$0.107B	0.00
Ovid Therapeutics (OVID)	United States	$0.107B	0.00
Codexis (CDXS)	United States	$0.107B	0.00
Cardiff Oncology (CRDF)	United States	$0.106B	0.00
Turn Therapeutics (TTRX)	United States	$0.106B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.105B	0.00
Immunic (IMUX)	United States	$0.105B	0.00
Citius Oncology (CTOR)	United States	$0.104B	0.00
Coya Therapeutics (COYA)	United States	$0.099B	0.00
Actuate Therapeutics (ACTU)	United States	$0.099B	0.00
Artiva Biotherapeutics (ARTV)	United States	$0.098B	0.00
Equillium (EQ)	United States	$0.097B	0.00
Agenus (AGEN)	United States	$0.097B	0.00
Chrome Holding (MEHCQ)	United States	$0.096B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.096B	0.00
Genelux (GNLX)	United States	$0.095B	0.00
Cognition Therapeutics (CGTX)	United States	$0.094B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.094B	0.00
BioStem Technologies (BSEM)		$0.093B	6.49
Precision BioSciences (DTIL)	United States	$0.091B	0.00
Spruce Biosciences (SPRB)	United States	$0.089B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.089B	0.00
Biomea Fusion (BMEA)	United States	$0.088B	0.00
OKYO Pharma (OKYO)		$0.088B	0.00
ATyr Pharma (ATYR)	United States	$0.087B	0.00
TuHURA Biosciences (HURA)	United States	$0.084B	0.00
EXoZymes (EXOZ)	United States	$0.084B	0.00
Tenax Therapeutics (TENX)	United States	$0.081B	0.00
BioHarvest Sciences (BHST)	Canada	$0.079B	0.00
MaxCyte (MXCT)	United States	$0.078B	0.00
MediciNova (MNOV)	United States	$0.077B	0.00
ImageneBio (IMA)	United States	$0.077B	0.00
Seres Therapeutics (MCRB)	United States	$0.074B	0.00
IBio (IBIO)	United States	$0.073B	0.00
XBiotech (XBIT)	United States	$0.072B	0.00
Scilex Holding (SCLX)	United States	$0.070B	0.00
Entera Bio (ENTX)	Israel	$0.070B	0.00
Pliant Therapeutics (PLRX)	United States	$0.069B	0.00
Annovis Bio (ANVS)	United States	$0.064B	0.00
Adicet Bio (ACET)	United States	$0.064B	0.00
Coeptis Therapeutics Holdings (COEP)	United States	$0.063B	0.00
Mereo BioPharma Group - (MREO)	United Kingdom	$0.062B	0.00
Radiopharm Theranostics - (RADX)	Australia	$0.059B	0.00
InflaRx (IFRX)	Germany	$0.056B	0.00
BeyondSpring (BYSI)	United States	$0.055B	0.00
Grace Therapeutics (GRCE)	United States	$0.055B	0.00
TScan Therapeutics (TCRX)	United States	$0.053B	0.00
Instil Bio (TIL)	United States	$0.053B	0.00
MiNK Therapeutics (INKT)	United States	$0.052B	0.00
Tevogen Bio Holdings (TVGN)	United States	$0.052B	0.00
MIRA Pharmaceuticals (MIRA)	United States	$0.049B	0.00
Galecto (GLTO)	Denmark	$0.048B	0.00
Zhengye Biotechnology Holding (ZYBT)	China	$0.048B	0.00
Q32 Bio (QTTB)	United States	$0.047B	0.00
Estrella Immunopharma (ESLA)	United States	$0.046B	0.00
NextCure (NXTC)	United States	$0.046B	0.00
Cingulate (CING)	United States	$0.046B	0.00
Kezar Life Sciences (KZR)	United States	$0.046B	0.00
Clene (CLNN)	United States	$0.045B	0.00
Aligos Therapeutics (ALGS)	United States	$0.043B	0.00
ABVC BioPharma (ABVC)	United States	$0.042B	0.00
CervoMed (CRVO)	United States	$0.042B	0.00
Elutia (ELUT)	United States	$0.041B	0.00
Xilio Therapeutics (XLO)	United States	$0.040B	0.00
Lisata Therapeutics (LSTA)	United States	$0.040B	0.00
INmune Bio (INMB)	United States	$0.039B	0.00
Generation Bio (GBIO)	United States	$0.038B	0.00
Celularity (CELU)	United States	$0.035B	0.00
Pluri (PLUR)	Israel	$0.035B	0.00
Tvardi Therapeutics (TVRD)	United States	$0.035B	0.00
RenovoRx (RNXT)	United States	$0.034B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.034B	0.00
PDS Biotechnology (PDSB)	United States	$0.033B	0.00
Jasper Therapeutics (JSPR)	United States	$0.033B	0.00
OnKure Therapeutics (OKUR)	United States	$0.033B	0.00
Oncobiologics (OTLK)	United States	$0.032B	0.00
Promis Neurosciences (PMN)	Canada	$0.032B	0.00
Atara Biotherapeutics (ATRA)	United States	$0.032B	2.04
Werewolf Therapeutics (HOWL)	United States	$0.032B	0.00
TELA Bio (TELA)	United States	$0.032B	0.00
Hyperion DeFi (HYPD)	United States	$0.032B	0.00
Alterity Therapeutics - (ATHE)	Australia	$0.031B	0.00
Rein Therapeutics (RNTX)	United States	$0.031B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.030B	0.00
Lantern Pharma (LTRN)	United States	$0.030B	0.00
Dyadic (DYAI)	United States	$0.030B	0.00
BRIACELL THERAP (BCTX)	Canada	$0.030B	0.00
AN2 Therapeutics (ANTX)	United States	$0.029B	0.00
Femasys (FEMY)	United States	$0.029B	0.00
Passage Bio (PASG)	United States	$0.028B	0.00
Exicure (XCUR)	United States	$0.027B	0.00
Athira Pharma (ATHA)	United States	$0.027B	0.00
IO Biotech (IOBT)	Denmark	$0.026B	0.00
Barinthus Biotherapeutics (BRNS)	United States	$0.026B	0.00
Medicus Pharma (MDCX)	United States	$0.025B	0.00
Boundless Bio (BOLD)	United States	$0.025B	0.00
Rallybio (RLYB)	United States	$0.025B	0.00
Dare Bioscience (DARE)	United States	$0.024B	0.00
Cue Biopharma (CUE)	United States	$0.024B	0.00
Aytu BioPharma (AYTU)	United States	$0.023B	0.00
Lixte Biotechnology Holdings (LIXT)	United States	$0.023B	0.00
Skye Bioscience (SKYE)	United States	$0.023B	0.00
Intensity Therapeutics (INTS)	United States	$0.022B	0.00
Neuphoria Therapeutics (NEUP)	United States	$0.022B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.022B	0.00
Senti Biosciences (SNTI)	United States	$0.021B	0.00
Apollomics (APLM)	United States	$0.021B	0.00
Anebulo Pharmaceuticals (ANEB)	United States	$0.020B	0.00
LeonaBio (LONA)	United States	$0.018B	0.00
IN8bio (INAB)	United States	$0.018B	0.00
Genenta Science S.p.A (GNTA)	Italy	$0.017B	0.00
FibroBiologics (FBLG)	United States	$0.016B	0.00
Pasithea Therapeutics (KTTA)	United States	$0.016B	0.00
Black Titan (BTTC)	United States	$0.016B	0.00
Lexaria Bioscience (LEXX)	Canada	$0.015B	0.00
Hoth Therapeutics (HOTH)	United States	$0.015B	0.00
Curis (CRIS)	United States	$0.015B	0.00
Polyrizon (PLRZ)	Israel	$0.015B	0.00
Applied Therapeutics (APLT)	United States	$0.014B	0.00
Quantum Biopharma (QNTM)	Canada	$0.014B	0.00
Allarity Therapeutics (ALLR)	United States	$0.014B	0.00
Cocrystal Pharma (COCP)	United States	$0.013B	0.00
NewcelX (NCEL)	Switzerland	$0.013B	0.00
Cadrenal Therapeutics (CVKD)	United States	$0.013B	0.00
Quince Therapeutics (QNCX)	United States	$0.013B	0.00
BioCardia (BCDA)	United States	$0.012B	0.00
Sensei Biotherapeutics (SNSE)	United States	$0.011B	0.00
Longeveron (LGVN)	United States	$0.011B	0.00
Bionano Genomics (BNGO)	United States	$0.011B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.011B	0.00
Soligenix (SNGX)	United States	$0.011B	0.00
BioAtla (BCAB)	United States	$0.010B	0.00
CalciMedica (CALC)	United States	$0.010B	0.00
Revelation Biosciences (REVB)	United States	$0.010B	0.00
Imunon (IMNN)	United States	$0.010B	0.00
Bolt Biotherapeutics (BOLT)	United States	$0.009B	0.00
Biofrontera (BFRI)	United States	$0.009B	0.00
Chemomab Therapeutics (CMMB)	Israel	$0.009B	0.00
Cuprina Holdings (Cayman) (CUPR)	Singapore	$0.009B	0.00
CollPlant Biotechnologies (CLGN)	Israel	$0.009B	0.00
Moleculin Biotech (MBRX)	United States	$0.009B	0.00
Novogen (KZIA)	Australia	$0.009B	0.00
Edesa Biotech (EDSA)	Canada	$0.008B	0.00
Beyond Air (XAIR)	United States	$0.008B	0.00
Purple Biotech (PPBT)	Israel	$0.007B	0.00
Gelteq (GELS)	Australia	$0.007B	0.00
Dogwood Therapeutics (DWTX)	United States	$0.007B	0.00
Mainz Biomed (MYNZ)	Germany	$0.007B	0.00
Mustang Bio (MBIO)	United States	$0.007B	0.00
Aptevo Therapeutics (APVO)	United States	$0.007B	0.00
GENPREX (GNPX)	United States	$0.006B	0.00
Alzamend Neuro (ALZN)	United States	$0.006B	0.00
Sunshine Biopharma (SBFM)	United States	$0.006B	0.00
IMMURON (IMRN)	Australia	$0.006B	0.00
Advanced Biomed (ADVB)	United States	$0.005B	0.00
Evogene (EVGN)	Israel	$0.005B	0.00
GT Biopharma (GTBP)	United States	$0.005B	0.00
VivoSim Labs (VIVS)	United States	$0.005B	0.00
BioAffinity Technologies (BIAF)	United States	$0.005B	0.00
Silexion Therapeutics Corp (SLXN)	Israel	$0.005B	0.00
Acurx Pharmaceuticals (ACXP)	United States	$0.005B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.005B	0.00
Cyclerion Therapeutics (CYCN)	United States	$0.005B	0.00
Creative Medical Technology Holdings (CELZ)	United States	$0.005B	0.00
Aprea Therapeutics (APRE)	United States	$0.004B	0.00
GeoVax Labs (GOVX)	United States	$0.004B	0.00
Silo Pharma (SILO)	United States	$0.004B	0.00
Dermata Therapeutics (DRMA)	United States	$0.004B	0.00
MetaVia (MTVA)	United States	$0.004B	0.00
Avalon GloboCare (ALBT)	United States	$0.004B	0.00
KALA BIO (KALA)	United States	$0.004B	0.00
Aspire Biopharma Holdings (ASBP)	United States	$0.004B	0.00
Propanc Biopharma Inc (PPCB)	Australia	$0.003B	0.00
AquaBounty Technologies (AQB)	United States	$0.003B	0.00
GRI Bio (GRI)	United States	$0.003B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.003B	0.00
Arcadia Biosciences (RKDA)	United States	$0.003B	0.00
Psyence Biomedical (PBM)	Canada	$0.003B	0.00
Enveric Biosciences (ENVB)	United States	$0.003B	0.00
HCW Biologics (HCWB)	United States	$0.003B	0.00
Artelo Biosciences (ARTL)	United States	$0.003B	0.00
Scinai Immunotherapeutics (SCNI)	Israel	$0.002B	0.00
Cardio Diagnostics Holdings (CDIO)	United States	$0.002B	0.00
CNS Pharmaceuticals (CNSP)	United States	$0.002B	0.00
Abpro Holdings (ABP)	United States	$0.002B	0.00
Bone Biologics (BBLG)	United States	$0.002B	0.00
Biorestorative Therapies (BRTX)	United States	$0.002B	0.00
Onconetix (ONCO)	United States	$0.002B	0.00
Ensysce Biosciences (ENSC)	United States	$0.002B	0.00
Virax Biolabs Group (VRAX)	United Kingdom	$0.001B	0.00
Biodexa Pharmaceuticals (BDRX)	United Kingdom	$0.001B	0.00
NuCana (NCNA)	United Kingdom	$0.000B	0.00
Aceragen (ACGN)	United States	$0.000B	0.00
ARAVIVE, INC (ARAV)	United States	$0.000B	0.00
Compugen (CGEN)	Israel	$0.000B	0.00
Cellectis S.A (CLLS)	France	$0.000B	0.00
Clovis Oncology (CLVSQ)	United States	$0.000B	0.00
Celyad SA (CYAD)	Belgium	$0.000B	0.00
CytoMed Therapeutics (GDTC)	Singapore	$0.000B	0.00
Galapagos (GLPG)	Belgium	$0.000B	0.00
Motif Bio Plc (MTFB)	United Kingdom	$0.000B	0.00
NeuroSense Therapeutics (NRSN)	Israel	$0.000B	0.00
PDL BioPharma (PDLI)	United States	$0.000B	0.00
Pharvaris (PHVS)	Netherlands	$0.000B	0.00
Pulmatrix (PULM)	United States	$0.000B	0.00
TFF Pharmaceuticals (TFFP)	United States	$0.000B	0.00
VectivBio Holding AG (VECT)	Switzerland	$0.000B	0.00